Heart Failure News and Research

RSS
Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.
Intensive blood pressure treatment lowers risk of cardiovascular events in high-risk patients

Intensive blood pressure treatment lowers risk of cardiovascular events in high-risk patients

Abelacimab significantly reduces bleeding risk in atrial fibrillation patients with stroke risk

Abelacimab significantly reduces bleeding risk in atrial fibrillation patients with stroke risk

Researchers encourage flexible approach to blood transfusion decisions for heart attack patients with anemia

Researchers encourage flexible approach to blood transfusion decisions for heart attack patients with anemia

Liberal blood transfusion may reduce recurrence risk, improve survival in heart attack patients with anemia

Liberal blood transfusion may reduce recurrence risk, improve survival in heart attack patients with anemia

Lowering sodium intake can help reduce blood pressure

Lowering sodium intake can help reduce blood pressure

New calculator estimates a person’s cardiovascular disease risk over the next 30 years

New calculator estimates a person’s cardiovascular disease risk over the next 30 years

Regular marijuana use may raise the risk for heart failure, stroke or heart attack

Regular marijuana use may raise the risk for heart failure, stroke or heart attack

Depression, anxiety and chronic stress increase risk for heart and brain health complications

Depression, anxiety and chronic stress increase risk for heart and brain health complications

AI tools may be effective at detecting heart valvular disease and predicting cardiovascular risk

AI tools may be effective at detecting heart valvular disease and predicting cardiovascular risk

Sotagliflozin provides kidney and heart benefits in patients with diabetes and chronic kidney disease

Sotagliflozin provides kidney and heart benefits in patients with diabetes and chronic kidney disease

Pharmacist prescribing for hypertension could save billions and millions of lives, study finds

Pharmacist prescribing for hypertension could save billions and millions of lives, study finds

High-impact clinical trial results  to be presented at ASN Kidney Week 2023

High-impact clinical trial results to be presented at ASN Kidney Week 2023

Expert consensus on the classification of acute atherothrombotic myocardial infarction by stage of tissue injury severity

Expert consensus on the classification of acute atherothrombotic myocardial infarction by stage of tissue injury severity

A four-stage classification of heart attack based on heart muscle damage

A four-stage classification of heart attack based on heart muscle damage

American Heart Association supports proposal to create new American Board of Cardiovascular Medicine

American Heart Association supports proposal to create new American Board of Cardiovascular Medicine

Canadian Cardiovascular Society releases new heart attack classification based on heart tissue damage

Canadian Cardiovascular Society releases new heart attack classification based on heart tissue damage

Extreme heat set to double, or even triple, heart-related deaths by mid-century, study warns

Extreme heat set to double, or even triple, heart-related deaths by mid-century, study warns

Study unravels the prognostic paradox of isolated cardiac sarcoidosis

Study unravels the prognostic paradox of isolated cardiac sarcoidosis

Diabetic patients with COVID-19: low antibody levels linked to worse outcomes

Diabetic patients with COVID-19: low antibody levels linked to worse outcomes

NF-κB activation during COVID-19 and its impact on patients with hypertension

NF-κB activation during COVID-19 and its impact on patients with hypertension

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.